Healthcare Clinical Trial Management Systems CTMS Market Size, Share, Analysis Report

Healthcare Clinical Trial Management Systems CTMS Market By Mode of delivery Analysis (Web-based, Cloud-based, On-premise); By Component Analysis (Software, Hardware, Services); By End User Analysis (Pharmaceutical industry, CROs) and By Regional Analysis – Global Forecast by

The Global Healthcare Clinical Trial Management Systems CTMS Market is expected to be around US$ 2.90 billion by 2028 and will grow at a CAGR of more than 11% in the given forecast period.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Oracle Corporation
  • Merge Healthcare Incorporated
  • Medidata Solutions Inc
  • PAREXEL International Corporation
  • BioClinica
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    11

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    Clinical trials that are used for trying out the efficacy and safety of a drug, medical devices, of every other healing product are presently at the upward push. A medical trial is performed for the identification of the outcomes of a selected medicine or clinical treatment method at the human body. Scientific trials are extraordinarily critical as a result of the massive investments expended on them and consequently want right control. A clinical trial control machine (CTMS) is a software program gadget used by the pharmaceutical and biotechnology industries for coping with scientific trials within scientific research. These structures manipulate and keep reporting, participant contact information, plans, music closing dates, and milestones.
     
    How Big is the Global Healthcare Clinical Trial Management Systems CTMS Market?

    The Global Healthcare Clinical Trial Management Systems CTMS Market is expected to be around US$ 2.90 billion by 2028 and will grow at a CAGR of more than 11% in the given forecast period.
     
    The major driving factors of Global Healthcare Clinical Trial Management Systems CTMS Market are as follows:
     
    •    Rising prevalence of chronic diseases
    •    Explosion number of healthcare endusers
    •    Growing number healthcare service providers 
    •    High accuracy of the information supply by clinical trial management systems
     
    The restraining factors of Global Healthcare Clinical Trial Management Systems CTMS Market are as follows:
     
    •    Long approvals and strictness in patient enrollment and recruitment
    •    contract and budget compromise and sanction
    •    Institutional Review Board approval 
    •    Availability of appropriate patient population
     
    The Global Healthcare Clinical Trial Management Systems CTMS Market is segmented on the lines of its mode of delivery, component, end user and regional. Based on mode of delivery segmentation it covers web-based, cloud-based and on-premise. Under component segmentation it covers software, hardware and services. End user is classified into pharmaceutical industry and CROs. The Global Healthcare Clinical Trial Management Systems CTMS Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
     
    This report provides:

    1) An overview of the global market for Healthcare Clinical Trial Management Systems CTMS and related technologies.
    2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
    3) Identifications of new market opportunities and targeted promotional plans for healthcare clinical trial management systems CTMS.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry. 

    REPORT SCOPE: 

    The scope of the report includes a detailed study of global and regional markets for Global Healthcare Clinical Trial Management Systems CTMS Market with the reasons given for variations in the growth of the industry in certain regions.
    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Oracle Corporation, Merge Healthcare Incorporated, Medidata Solutions Inc., PAREXEL International Corporation, BioClinica, MedNet Solutions, Inc., Bio-Optronics, Inc., DSG, Inc., eClinForce, Inc., and Forte Research Systems, Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. 
    The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players. 

    The Global Healthcare Clinical Trial Management Systems CTMS Market has been segmented as below:

    By Mode of delivery Analysis

    •    Web-based
    •    Cloud-based
    •    On-premise 

    By Component Analysis

    •    Software
    •    Hardware
    •    Services
     
    By End User Analysis

    •    Pharmaceutical industry
    •    CROs 

    By Regional Analysis

    •    North America
    •    Europe
    •    Asia-Pacific
    •    Rest of the World
     
    Reasons to Buy this Report: 

    1) Obtain the most up to date information available on all Global Healthcare Clinical Trial Management Systems CTMS Market.
    2) Identify growth segments and opportunities in the industry.
    3) Facilitate decision making on the basis of strong historic and forecast of Global Healthcare Clinical Trial Management Systems CTMS Market data.
    4) Assess your competitor’s refining portfolio and its evolution.

    Customization:

    We can offer you custom research reports as per client’s special requirements.

    Below are our New Reports :-

    Drug Discovery Informatics Market

    E Health Market

    Endoscope Reprocessing Market

    European healthcare Market

    E-Prescribing Market

    1 INTRODUCTION      

        1.1    Key Take Aways    
        1.2    Report Description    
        1.3    Markets Covered    
        1.4    Stakeholders    
        1.5    Research Methodology    
            1.5.1    Market Size    
            1.5.2    Market Share    
            1.5.3    Key Data Points From Secondary Sources    
            1.5.4    Key Data Points From Primary Sources

    2 Research Methodology

        2.1 Research Design
               2.1.1 Secondary Data
                        2.1.1.1 Key Data From Secondary Sources
               2.1.2 Primary Data
                        2.1.2.1 Key Data From Secondary Sources
        2.2 Market Size Estimation
               2.2.1 Market Size Estimation Steps
               2.2.2 End-User Analysis
               2.2.3 Bottom-Up Approach
               2.2.4 Top-Up Approach
               2.2.5 Primary Research – Sampling Frame
        2.3 Data Triangulation and Research Assumptions

    3 Executive Summary

        3.1 Introduction
        3.2 CTMS Market, By End-User (2016)
        3.3 CTMS Market, By Delivery Mode, 2019 vs 2025
        3.4 CTMS Market Share, By Type, 2016
        3.5 CTMS Market Share, By Component, 2016  
        3.6 CTMS Market, By Geography  
        3.7 Competitive Landscape

    4 Premium Insights

        4.1 Market Opportunities for Growth in CTMS Market (2019-2025)
        4.2 Asia-Pacific to Lead the Market Growth for CTMS During the Forecast Period
        4.3 Global CTMS Market, By End-User and Mode of Delivery (2016)  
        4.4 Global CTMS Market, By Component and Type, 2019 vs 2025

    5 Market Dynamics

        5.1 Overview
        5.2 Key Market Drivers
               5.2.1 Rising R&D Expenditure of Pharmaceutical, Life Science and Clinical Research Industries
               5.2.2 Rising Number of Clinical Trials
               5.2.3 New Product Launches
               5.2.4 Increasing Customer Base Owing to Adoption of CTMS Solutions
               5.2.5 Rising Adoption of CTMS Due to Advantages Provided By It
        5.3 Key Market Restraints
               5.3.1 Budget Constraints
               5.3.2 Lack of Skilled Professionals
        5.4 Key Market Opportunities
               5.4.1 Increasing Outsourcing of Clinical Trials to Cros in Asian Countries
               5.4.2 Use of Platform-As-A-Service (PaaS) Platform and Mobile Computing
        5.5 Key Market Trends
               5.5.1 Collaborative Ctms: Integration of CTMS With Other Software Such as His, Emr and Edc

    6 CTMS Market, By End-User

        6.1 Overview
        6.2 Pharmaceutical and Biopharmaceutical Companies  
        6.3 Contract Research Organizations
        6.4 Medical Device Companies
        6.5 Others

    7 CTMS Market, By Delivery Mode

        7.1 Overview
        7.2 Web-Based (Hosted) CTMS  
        7.3 Licensed Enterprise (On Premise) CTMS
        7.4 Cloud-Based (SaaS) CTMS

    8 CTMS Market, By Component

        8.1 Overview
        8.2 Software  
        8.3 Services

    9 CTMS Market, By Component

       9.1 Overview
        9.2 Enterprise CTMS  
        9.3 Site CTMS

    10 Geographic Analysis

         10.1 Overview
         10.2 North America
                 10.2.1 Significant Number of Ongoing Clinical Trials in the Region
                 10.2.2 Rising Government Support for Clinical Trial
         10.3 Europe
                 10.3.1 Government Support
                 10.3.2 Growing Biosimilars Market Key Driver of Clinical Activities in Europe
         10.4 Asia-Pacific
                 10.4.1 Increasing Number of Clinical Trials in the Region
                 10.4.2 Government Initiatives in the Region
         10.5 Rest of the World  
                 10.5.1 Favorable Clinical Trials Regulation in Brazil and Mexico
                 10.5.2 Investment in Middle East

    11 Competitive Intelligence

        11.1 Global CTMS Solutions Market Share, By Key Player, 2015
         11.2 Competitive Profile Matrix – Top Three Players
         11.3 Competitive Situation and Trends

    12 Company Profiles and Analysis

         12.1 Overview
         12.2 Oracle Corporation
         12.3 Medidata Solutions, Inc.
         12.4 Parexel International Corporation
         12.5 Bioclinica, Inc.
         12.6 Bio-Optronics, Inc.
         12.7 Merge Healthcare Incorporated (An IBM Company)
         12.8 Datatrak International, Inc.  
         12.9 Veeva Systems, Inc.
         12.10 DSG Inc. (Document Solutions Group)  
         12.11 Eclinforce, Inc.  
         12.12 ERT
         12.13 Forte Research Systems, Inc.
         12.14 Mednet Solutions, Inc.

    The Global Healthcare Clinical Trial Management Systems CTMS Market has been segmented as below:
     
    By Mode of delivery Analysis

    •    Web-based
    •    Cloud-based
    •    On-premise 

    By Component Analysis

    •    Software
    •    Hardware
    •    Services

    By End User Analysis

    •    Pharmaceutical industry
    •    CROs 

    By Regional Analysis

    •    North America
    •    Europe
    •    Asia-Pacific
    •    Rest of the World

    Got a question? We've got answers. If you have some other questions, see our support center.

    The market is expected to grow at a CAGR of 11% during the study period (2023-2028)
    The Global Healthcare Clinical Trial Management Systems CTMS Market is expected to be around US$ 2.90 billion by 2028
    The segment included in the Healthcare Clinical Trial Management Systems CTMS Market is Mode of delivery, Component, End User and region.
    Some key players operating in the Healthcare Clinical Trial Management Systems CTMS Market include Oracle Corporation, Merge Healthcare Incorporated, Medidata Solutions Inc., PAREXEL International Corporation, BioClinica, MedNet Solutions, Inc., Bio-Optronics, Inc
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports